Orphan designation: temozolomide Treatment of neuroblastoma, 21/08/2019 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 15 November 2024 - 12:10

Orphan designation: temozolomide Treatment of neuroblastoma, 21/08/2019 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-19-2188

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters